Literature DB >> 6502338

Meningitis caused by multiply antibiotic-resistant viridans streptococci.

J Goldfarb, G P Wormser, J H Glaser.   

Abstract

Two patients are described with meningitis caused by multiply antibiotic-resistant strains of viridans streptococci; both isolates were resistant to penicillin (MIC greater than 3 micrograms/ml) (4.8 U/ml) and to several other antimicrobial agents. Our findings underscore the importance of doing in vitro sensitivity testing with clinical isolates of viridans streptococci to determine appropriate therapy for infected patients. Multiply antibiotic-resistant strains of viridans streptococci have also been recently isolated in the same populations in South Africa in which the prevalence of resistant Streptococcus pneumoniae is high. Therefore, isolation of resistant clinical strains of viridans streptococci may suggest the need for in vitro surveillance of emerging antibiotic resistance in both streptococcal species.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6502338     DOI: 10.1016/s0022-3476(84)80072-4

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  8 in total

1.  Childhood meningitis caused by enterococci and viridans streptococci.

Authors:  C T Koorevaar; P G Scherpenzeel; H J Neijens; G Derksen-Lubsen; G Dzoljic-Danilovic; R de Groot
Journal:  Infection       Date:  1992 May-Jun       Impact factor: 3.553

2.  Prevention of viridans-group streptococcal septicemia in oncohematologic patients: a controlled comparative study on the effect of penicillin G and cotrimoxazole.

Authors:  H F Guiot; J W van der Meer; P J van den Broek; R Willemze; R van Furth
Journal:  Ann Hematol       Date:  1992-06       Impact factor: 3.673

3.  A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis.

Authors:  W V Kern; B Hay; P Kern; R Marre; R Arnold
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

4.  In vitro antimicrobial susceptibility of viridans streptococci isolated from blood cultures.

Authors:  E Potgieter; M Carmichael; H J Koornhof; L J Chalkley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-06       Impact factor: 3.267

5.  Streptococcal bacteremia in adult patients with leukemia undergoing aggressive chemotherapy. A review of 55 cases.

Authors:  W Kern; E Kurrle; T Schmeiser
Journal:  Infection       Date:  1990 May-Jun       Impact factor: 3.553

6.  Prevalence of penicillin-resistant viridans streptococci in healthy children and in patients with malignant haematological disorders.

Authors:  H F Guiot; L J Corel; J M Vossen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-08       Impact factor: 3.267

7.  In vitro activities of 22 beta-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood.

Authors:  F Alcaide; J Liñares; R Pallares; J Carratala; M A Benitez; F Gudiol; R Martin
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191

8.  Species-specific difference in antimicrobial susceptibility among viridans group streptococci.

Authors:  Sejong Chun; Hee Jae Huh; Nam Yong Lee
Journal:  Ann Lab Med       Date:  2015-02-12       Impact factor: 3.464

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.